What's Actually in Your Dog's Calming Chews
L-theanine, chamomile, valerian, melatonin, CBD, probiotics — an ingredient-by-ingredient breakdown of what has evidence, what doesn't, and what "proprietary blend" is hiding.
Published
Apr 8, 2026
Updated
Apr 8, 2026
References
5 selected
This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.
Flip the bag over
The front of a calming chew package tells you almost nothing. Every brand uses the same vocabulary — “calming,” “soothing,” “stress support” — regardless of whether the formula contains one active ingredient or seven, and regardless of the dose. The useful information is on the back, in the ingredient panel and the supplement facts section, where you can see what the product actually contains and (sometimes) how much.
Most calming chews draw from the same pool of nine or ten ingredients: L-theanine, chamomile, valerian root, passionflower, melatonin, CBD, probiotics, alpha-casozepine, tryptophan, and thiamine. A few products use just one. Most combine three to six. The evidence behind each ingredient varies from peer-reviewed canine trials to centuries-old herbal tradition with no controlled dog studies at all.
That gap between marketing claims and published evidence is the reason this guide exists. Knowing what each ingredient does — and what we actually know about whether it works in dogs — puts you in a better position than reading five-star Amazon reviews, which are subject to the same placebo and expectation bias that complicates clinical trials.
Key takeaway
The front of the package is marketing. The ingredient panel on the back is where you learn what the product can and cannot do.
Ingredient-by-ingredient: what has evidence and what doesn't
Each ingredient below gets an evidence tier based on the quality and quantity of canine-specific research. “Strong” means multiple blinded or placebo-controlled canine studies. “Moderate” means some canine data, but with methodological limits. “Weak” means the evidence is mostly extrapolated from human or rodent studies. “Insufficient” means we don't have enough canine data to draw a conclusion either way.
Alpha-casozepine
Evidence tier: Strong
Alpha-casozepine is a decapeptide derived from tryptic hydrolysis of bovine alpha-s1 casein (milk protein). A 2022 study using flumazenil as an antagonist confirmed that its anxiolytic-like properties depend on GABA-A receptor benzodiazepine binding sites (Benoit et al., PMCID: PMC9182760), though with approximately 10,000 times lower affinity than diazepam — which likely explains why it reduces anxiety measures without producing sedation or dependence. Published canine studies include a blinded trial comparing it to selegiline on owner-reported emotional disorder scores, and a separate blinded study showing improvement in both behavioral measures and cortisol levels over 65 days in anxious dogs (reviewed in Riemer, PMCID: PMC10705068). Marketed as Zylkene. Among the common calming chew ingredients, this one has the most methodologically controlled canine data.
L-theanine
Evidence tier: Moderate
L-theanine (gamma-glutamylethylamide) is a non-proteinogenic amino acid from tea leaves that structurally resembles glutamate. In human EEG studies, it promotes alpha brain wave activity — a state of relaxed alertness distinct from sedation. Canine studies are smaller and less controlled: the Pike et al. (2015) open-label study of Anxitane found owner-reported improvements in storm-sensitive dogs, but had a 31 percent dropout rate and no placebo group. A separate blinded, placebo-controlled trial (DePorter et al., 2012) tested Harmonease — a chewable combining L-theanine with magnolia and phellodendron extracts — and found reduced fear behavior, but the multi-ingredient design means L-theanine's individual contribution cannot be separated from the other actives. The directional signal across these studies is positive, but large-scale standalone canine proof is missing. The full L-theanine guide covers each study in detail.
L-tryptophan
Evidence tier: Moderate (mixed results)
L-tryptophan is an essential amino acid and precursor to serotonin synthesis. The rationale is straightforward: more tryptophan should increase serotonin availability, which should reduce anxiety. In practice, the canine data are mixed. A controlled study examining graded dietary tryptophan concentrations in dogs did not find consistent, significant behavioral differences across diet groups overall, though some individual behavioral measures varied. Other studies targeting anxiety and obsessive-compulsive behaviors have similarly found no clear effect from tryptophan supplementation alone. A 2025 crossover study (PMCID: PMC12339541) showed cortisol reduction in dogs receiving a treat combining CBD, tryptophan, and alpha-casozepine, but could not attribute the effect to tryptophan specifically. The combination-product problem is a recurring theme: tryptophan appears in many calming chews, but its independent anxiolytic contribution in dogs remains undemonstrated.
CBD (Cannabidiol)
Evidence tier: Moderate (growing, but anxiety-specific data limited)
CBD has a growing body of canine pharmacokinetic and safety data, but most published efficacy studies focus on osteoarthritis and pain rather than behavioral anxiety. The 2025 randomized crossover study (PMCID: PMC12339541) found cortisol attenuation with a CBD-containing treat during car-travel stress, but most behavioral outcome measures in that trial did not reach statistical significance. CBD also undergoes extensive hepatic CYP450 metabolism, which creates a more complex drug interaction profile than most other calming ingredients. Third-party lab testing (Certificate of Analysis) is non-negotiable for CBD products because of the gap between what labels claim and what products actually contain.
Melatonin
Evidence tier: Weak (widely used, but canine anxiety data thin)
Melatonin is an endogenous hormone that regulates circadian rhythm. It is one of the most commonly included ingredients in calming chews, and veterinarians frequently recommend it for situational noise anxiety. Despite that widespread clinical use, the canine behavioral pharmacology literature is thin — most supporting evidence comes from mammalian sleep and circadian research rather than controlled canine anxiolysis trials. The practical concern: melatonin can cause drowsiness, which means it may produce sedation rather than genuine anxiolysis. Products containing melatonin are generally better suited for evening or pre-event use than for daily daytime support. The melatonin guide covers dosing, xylitol risk, and safety in depth.
Probiotics (Gut-Brain Axis)
Evidence tier: Weak to Moderate (mechanism plausible, behavioral data early)
The microbiome-gut-brain axis is a legitimate area of veterinary neuroscience. Reviews (PMCID: PMC10827376) describe bidirectional signaling pathways — vagal afferent modulation, microbial metabolite production, HPA axis regulation — that could plausibly influence canine stress responses. Purina's BL999 probiotic strain has a published canine study showing behavioral changes over several weeks. But the broader probiotic category is highly strain-specific, and most strains found in calming chews have not been individually tested for behavioral effects in dogs. The mechanism is plausible; the evidence for specific products is still catching up.
Chamomile (Matricaria chamomilla)
Evidence tier: Insufficient (no controlled canine anxiety trials)
Chamomile contains apigenin, a flavonoid that binds to benzodiazepine receptors in vitro and has shown anxiolytic effects in rodent models and a few human clinical trials. In shelter settings, chamomile aromatherapy has been associated with increased resting behavior, but no controlled oral-dosing study has tested chamomile's anxiolytic effect in dogs. It appears on ingredient lists frequently because of its long herbal tradition and consumer familiarity, not because of canine-specific evidence.
Valerian root (Valeriana officinalis)
Evidence tier: Insufficient (canine data limited to aromatherapy)
Valerian's proposed mechanism involves modulation of GABA-A receptors via valerenic acid. Human systematic reviews describe mild anxiolytic and sleep-promoting effects, though the evidence is mixed. In dogs, the Pet Remedy study (PMCID: PMC5126766) tested a valerian-based essential oil blend on shelter dogs and found some behavioral changes, but this was an aromatherapy application, not an oral supplement study. No published controlled trial has evaluated oral valerian for canine anxiety. The ingredient may have activity, but we genuinely do not know at what oral dose — if any — it produces behavioral effects in dogs.
Passionflower (Passiflora incarnata)
Evidence tier: Insufficient (appears in combination products only)
Passionflower extracts have GABAergic activity in rodent models and some positive results in human anxiety trials. In the canine literature, passionflower appears only as one component in multi-ingredient formulations — the DiRelax RCT (PMCID: PMC8868118) included passionflower at 8 mg/kg alongside several other active ingredients, and a 2025 study (PMCID: PMC12696704) tested a passionflower-containing supplement in senior dogs for inflammatory markers, not anxiety behavior. No study has isolated passionflower's independent anxiolytic contribution in dogs.
Thiamine (Vitamin B1)
Evidence tier: Insufficient (no canine anxiety studies)
Thiamine is a water-soluble B vitamin involved in glucose metabolism and nerve function. Severe deficiency causes neurological symptoms, which has led to the reasoning that supplementation might support nervous system health under stress. But there is no published canine study linking thiamine supplementation to anxiety reduction. It appears in several calming chews (including VetriScience Composure and NaturVet Quiet Moments) as a supporting ingredient, and is unlikely to cause harm, but its independent contribution to calming effects remains undemonstrated.
For a broader look at how these ingredients fit into an anxiety management plan — not just what they are, but when and how to use them — the calming supplements guide covers the strategic picture.
Key takeaway
Alpha-casozepine has the most controlled canine data at the ingredient level. L-theanine has moderate but limited data. Most botanical ingredients lack controlled canine anxiety studies. Keep in mind that evidence for a specific ingredient does not automatically transfer to every product containing it.
Not sure which ingredient profile matches your dog's anxiety pattern? Walk Scout through a recent episode and get a recommendation based on trigger type, body weight, and what you've already tried.
The “proprietary blend” problem
A proprietary blend is a mixture of ingredients listed under a single combined weight, without disclosing the amount of each individual component. In human dietary supplements, this practice is legal under DSHEA (Dietary Supplement Health and Education Act) regulations — the manufacturer must list ingredients in descending order by weight, but can withhold per-ingredient quantities. Pet supplement regulations, which fall under FDA-CVM rather than DSHEA, are even less standardized (Boothe, PMCID: PMC7802882).
Why does this matter? Consider a calming chew that lists a “Calming Complex — 500 mg” containing L-theanine, chamomile, valerian, and passionflower. The L-theanine could be 200 mg (within the range used in published studies) or 15 mg (a token amount for label appeal). You have no way to know. The descending order rule tells you which ingredient weighs the most, but the gap between first and last could be enormous.
This is not theoretical. Because proprietary blend regulations only require listing the total blend weight, a manufacturer can include an ingredient at a fraction of the dose used in published studies while still listing that ingredient on the label. The consumer sees the ingredient name and assumes a meaningful dose. The label is technically accurate. The implication is misleading.
The red flags: any label that says “proprietary blend,” “calming complex,” or “soothing matrix” without per-ingredient milligram disclosure is withholding the information you need to evaluate the product. Transparent brands list exact milligram amounts for each active ingredient per serving. That transparency is a minimum quality signal, not a bonus.
Key takeaway
If a label says “proprietary blend” without per-ingredient milligrams, you cannot evaluate whether the active ingredients are present at meaningful doses. Transparent labeling is the baseline.
What the NASC seal means — and what it doesn't
The NASC quality seal is the pet supplement industry's primary self-regulatory mark. Earning it requires a manufacturer to demonstrate cGMP compliance, submit to facility audits, maintain label accuracy, and participate in adverse event surveillance (Boothe, PMCID: PMC7802882).
What it tells you: the product was manufactured in a facility that follows quality control protocols, the label ingredients match what's in the product, and the company tracks adverse reactions. In an industry where FDA enforcement is limited and no pre-market approval is required, this is a meaningful quality floor.
What it does not tell you: that the product works. The NASC seal is a manufacturing standard, not a clinical efficacy endorsement. A product can carry the seal while containing ingredients with zero peer-reviewed evidence of calming effects in dogs — and many do. The seal says the product is what it claims to be. It says nothing about whether what it claims to be will help your dog. Both matter, but they answer different questions.
Key takeaway
The NASC seal is a manufacturing quality check, not proof that a product works. Look for both: the seal (quality floor) and per-ingredient evidence (efficacy signal).
How to read a calming chew label in 60 seconds
You do not need a biochemistry degree. Five things, checked in order, will filter out most of the noise.
- Per-ingredient milligrams. Does each active ingredient have its own milligram amount listed per serving? If the label uses a “proprietary blend” or “calming complex” total instead, you cannot evaluate the dose of any single ingredient.
- Weight-based dosing chart. A 12-pound Cavalier and an 85-pound German Shepherd metabolize supplements at different rates. Products that scale the dose across weight brackets give you better guidance than a uniform serving size regardless of body mass.
- NASC quality seal. Printed on the packaging itself, not just mentioned on the brand's website. Confirms cGMP facility standards and adverse event surveillance participation.
- Active ingredients you recognize. Cross-reference the ingredient list with the evidence tiers above. A product built around alpha-casozepine or L-theanine has a different evidence basis than one built around chamomile and passionflower. Neither is necessarily wrong, but you should know which category you're buying into.
- Third-party testing (CBD products only). Any CBD calming chew should have a current Certificate of Analysis from an ISO 17025-accredited independent lab. This verifies cannabinoid concentration, heavy metal levels, pesticide residues, and microbial contaminants. If the manufacturer does not publish COAs, move on.
One more thing: check the “inactive ingredients” or “other ingredients” list for xylitol, which is toxic to dogs even in small amounts. It appears in some chewable supplements as a sweetener. Products listing xylitol or birch sugar should be avoided regardless of how good the active ingredient panel looks.
Key takeaway
Five checks: per-ingredient milligrams, weight-based dosing, NASC seal, evidence-backed actives, and (for CBD) third-party lab testing. Also scan inactive ingredients for xylitol or birch sugar — both are toxic to dogs.
Frequently asked questions
What is the best-studied ingredient in calming chews for dogs?
Alpha-casozepine has the strongest canine-specific evidence among the common calming chew ingredients — multiple blinded studies showing behavioral and cortisol improvements. L-theanine has moderate evidence with a positive directional signal, particularly for noise-related anxiety, though standalone proof from large controlled trials is still missing. Most botanical ingredients (chamomile, valerian, passionflower) lack controlled canine anxiety studies entirely.
What does “proprietary blend” mean on a calming chew label?
It means the manufacturer lists the total weight of a combined ingredient mixture without telling you how much of each individual ingredient is included. You see the ingredient names, but not the doses. A product could list L-theanine first in a 500 mg proprietary blend and contain 15 mg of it. Transparent labels disclose per-ingredient milligram amounts, which lets you compare what's in the product to what was used in published studies.
Does the NASC seal mean a calming chew works?
No. The NASC quality seal confirms cGMP facility compliance, label accuracy, and adverse event surveillance participation. It is a manufacturing standard, not a clinical endorsement. A product can carry the seal while containing ingredients with no peer-reviewed evidence of calming effects in dogs. The seal answers “is this product made well?” not “will this product help my dog?”
Evidence-informed guide
Pawsd guides are educational and not a substitute for veterinary advice. These pages draw from selected open-access peer-reviewed veterinary research, with full-text sources linked below.
Selected references
Scandurra A et al. Animals (Basel). 2022;12(4):435. PMCID: PMC8868118. RCT of a multi-ingredient calming nutraceutical in dogs.
Front Vet Sci. 2025;12:1632868. PMCID: PMC12339541. Randomized crossover study showing cortisol attenuation with a CBD-plus-amino-acid treat during car-travel stress.
Vet Med Int. 2024;2024:2856759. PMCID: PMC10827376. Review of microbiome-gut-brain signaling pathways relevant to canine anxiety.
Riemer S. Animals (Basel). 2023;13(23):3664. PMCID: PMC10705068. Practitioner-focused evidence review covering L-theanine, pressure wraps, pheromones, and desensitization.
Benoit S et al. Nutrients. 2022;14(11):2212. PMCID: PMC9182760. Rat model confirming alpha-casozepine acts via GABA-A benzodiazepine sites.
Ingredients matter less than how they match your dog.
Tell Scout about your dog's anxiety triggers, body weight, and what you've already tried. Scout will recommend specific products based on the ingredient profile that fits — not just what's popular.
Match ingredients to your dog→Related Reading
Dog Calming Supplements: What the Evidence Can and Cannot Tell Us
CBD, calming blends, probiotics, melatonin, and botanicals. What current canine evidence can and cannot tell us, and where supplements may fit in a broader anxiety plan.
CBD for Dogs: What Current Veterinary Research Can and Cannot Tell Us
The evidence on CBD for dogs is mixed and still limited. What peer-reviewed research says about safety, efficacy, drug interactions, and quality — and how to opt out of CBD product recommendations.
Hemp vs CBD for Dogs: What's Actually in the Product and Why It Matters
Hemp seed oil and CBD oil come from the same plant but are chemically, legally, and functionally different. What peer-reviewed research and regulatory bodies say about each, and why the distinction matters for your dog.
Separation Anxiety in Dogs: Signs, Triggers, and Management
Separation-related distress can begin before you leave. How routine cues shape the pattern, how to distinguish it from boredom, and which management approaches are commonly used.
Products mentioned in this guide
This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.